Reasoning in the loop: antibody lead optimization by probing mechanism and measurement
Source check: Source checked. Not independent scientific confirmation.
Finding: In two controlled antibody lead-optimization campaigns, Claude and researchers identified misleading thermal assay proxies, revised measurements and experimentally improved anti-albumin VHH and anti-mesothelin scFv leads. Small final-lead replicate counts; no mammalian expression, stress testing or clinical validation.
Technology: Claude general-purpose AI agent
Family Claude: profile · models page
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Claude general-purpose AI agent
- Test and result
- The two controlled antibody lead-optimization campaigns report measured improvements in affinity, thermal stability and aggregation after the team identified misleading thermal assay proxies. Small final-lead replicate counts; no mammalian expression, stress testing or clinical validation.
- Limitation / still unknown
- No independent replication or clinical utility established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://arxiv.org/html/2611.19812v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.